Kappa and Mu Opioid Receptors in Chronic Cough: Current Evidence and Future Treatment. [PDF]
Birring SS+7 more
europepmc +1 more source
Dispensing hope: leveraging distribution boxes to enhance low-barrier access to naloxone in healthcare settings. [PDF]
Kothe N, Gray A, Guthrie S, Londner M.
europepmc +1 more source
Extended-Release Buprenorphine Could Overcome Barriers to Medical Treatment of Opioid Use Disorder in At-Risk Populations. [PDF]
Davis SA, Verrastro G, Fagan EB.
europepmc +1 more source
HOMOBENZOMORPHAN COMPOUNDS WITH A POTENT NARCOTIC ANTAGONIST PROPERTY
Seiichi Nurimoto+3 more
openalex +1 more source
Opioids With or Without Low-Dose Naloxone During the Perioperative Period: A Systematic Review With Meta-Analysis. [PDF]
Mao B, Wang X, Zhang X, Chen M.
europepmc +1 more source
Cohort profile: the provincial opioid agonist treatment cohort in Ontario, Canada. [PDF]
Morin KA+3 more
europepmc +1 more source
Exploring the possible mechanism of low-dose naloxone exposure improving the immune microenvironment of gastric cancer tumors. [PDF]
Min X+6 more
europepmc +1 more source
Impact of UNODC/WHO S-O-S (stop-overdose-safely) training on opioid overdose knowledge and attitudes among people at high or low risk of opioid overdose in Kazakhstan, Kyrgyzstan, Tajikistan and Ukraine. [PDF]
Dietze P+12 more
europepmc +1 more source
Pacific Information Service on Street-Drugs May 1976 [PDF]
School of Pharmacy
core +1 more source